Meeder Asset Management’s Sight Sciences SGHT Stock Holding History

Meeder Asset Management’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5	Closed	–	–	1787
2022 Q3	$0	Buy	+5	New	+$42	﹤0.01%	2339

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Meeder Asset Management's SGHT Position: Q4 2022 in Review

Meeder Asset Management sold out of Sight Sciences (SGHT) in Q4 2022, closing a stake of 5 shares.

Meeder Asset Management first reported a position in SGHT in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 66 funds tracked by Wall St. Rank hold SGHT as of Q4 2022.

Meeder Asset Management reported no remaining Sight Sciences position as of Q4 2022 after selling out during the quarter.
Meeder Asset Management sold 5 Sight Sciences shares in Q4 2022.
Meeder Asset Management first reported a position in Sight Sciences in Q3 2022 and held it in 1 quarter.
Meeder Asset Management's Sight Sciences position peaked at $0 in Q3 2022.
66 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.